Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TNXPTNXP
4 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in TONIX PHARMACEUTICALS HOLDIN

Yes. Citadel Advisors holds 195,859 shares of TNXP (Tonix Pharmaceuticals Holdin), worth $2.5M, as of its Q2 2026 13F filing. It reduced the position by 272,853 shares (-58.2%) from Q1 2026. Citadel Advisors has held TNXP since Q1 2026, across 2 quarterly 13F filings.

Current Value

$2.5M

Current Shares

195,859

Total Value Change

+$2.2M

Total Shares Change

+188,782

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
195,859
-58.2%
$2.5M0.0%$12.76
0
2026-Q1
New
468,712
-
$6.4M0.0%$13.75
38
2025-Q3
Exited
0
-100.0%
$00.0%$24.16
0
2025-Q2
New
7,077
-
$254,6300.0%$35.98
35

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used